Latency-associated protein Acr1 impairs dendritic cell maturation and functionality: A possible mechanism of immune evasion by mycobacterium tuberculosis

Journal of Infectious Diseases

Volumn 209, Issue 9, 2014, Pages 1436-1445

  Siddiqui, Kaneez F ^a   Amir, Mohammed ^a   Gurram, Rama Krishna ^a   Khan, Nargis ^a   Arora, Ashish ^b   Rajagopal, Kammara ^a   Agrewala, Javed N ^a  

^a INSTITUTE OF MICROBIAL TECHNOLOGY   (India)

^b CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Acr1: alpha crystallin antigen; dendritic cells; immunosuppression; Mycobacterium tuberculosis

Indexed keywords

ACR1: ALPHA CRYSTALLIN ANTIGEN; DENDRITIC CELLS; IMMUNOSUPPRESSION; MYCOBACTERIUM TUBERCULOSIS;

ALPHA-CRYSTALLINS; ANIMALS; ANTIGENS, BACTERIAL; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; HOST-PATHOGEN INTERACTIONS; IMMUNE EVASION; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; STAT3 TRANSCRIPTION FACTOR; STAT6 TRANSCRIPTION FACTOR; T-LYMPHOCYTES; TUBERCULOSIS;

EID: 84898911957     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jit595     Document Type: Article

References (50)

1. Sharma N, Agrewala JN. Potent role of vaccines prepared from macrophages infected with live bacteria in protection against Mycobacterium tuberculosis and Salmonella Typhimurium infections. J Infect Dis 2004; 190:107-14
2. Rohde KH, Veiga DF, Caldwell S, Balazsi G, Russell DG. Linking the transcriptional profiles and the physiological states of Mycobacterium tuberculosis during an extended intracellular infection. PLoS Pathog 2012; 8:e1002769
3. Gomez JE, McKinney JD. M. tuberculosis persistence, latency, and drug tolerance. Tuberculosis (Edinb) 2004; 84:29-44
4. Flynn JL, Chan J. Immune evasion by Mycobacterium tuberculosis: Living with the enemy. Curr Opin Immunol 2003; 15:450-5
5. Wolf AJ, Linas B, Trevejo-Nunez GJ, et al. Mycobacterium tuberculosis infects dendritic cells with high frequency and impairs their function in vivo. J Immunol 2007; 179:2509-19
6. Giacomini E, Iona E, Ferroni L, et al. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J Immunol 2001; 166:7033-41
7. Andersen P. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins. Infect Immun 1994; 62:2536-44
8. Beatty WL, Russell DG. Identification of mycobacterial surface proteins released into subcellular compartments of infected macrophages. Infect Immun 2000; 68:6997-7002
9. Roche PW, Triccas JA, Avery DT, Fifis T, Billman-Jacobe H, Britton WJ. Differential T cell responses to mycobacteria-secreted proteins distinguish vaccination with bacille Calmette-Guerin from infection with Mycobacterium tuberculosis. J Infect Dis 1994; 170:1326-30
10. Salam N, Gupta S, Sharma S, et al. Protective immunity to Mycobacterium tuberculosis infection by chemokine and cytokine conditioned CFP-10 differentiated dendritic cells. PLoS One 2008; 3:e2869
11. Chatterjee S, Dwivedi VP, Singh Y, et al. Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner. PLoS Pathog 2011; 7:e1002378
12. Latchumanan VK, Singh B, Sharma P, Natarajan K. Mycobacterium tuberculosis antigens induce the differentiation of dendritic cells from bone marrow. J Immunol 2002; 169:6856-64
13. Demissie A, Leyten EM, Abebe M, et al. Recognition of stagespecific mycobacterial antigens differentiates between acute and latent infections with Mycobacterium tuberculosis. Clin Vaccine Immunol 2006; 13:179-86
14. Gordillo S, Guirado E, Gil O, et al. Usefulness of acr expression for monitoring latent Mycobacterium tuberculosis bacilli in 'in vitro' and 'in vivo' experimental models. Scand J Immunol 2006; 64: 30-9
15. Shi L, Jung YJ, Tyagi S, Gennaro ML, North RJ. Expression of Th1-mediated immunity in mouse lungs induces a Mycobacterium tuberculosis transcription pattern characteristic of nonreplicating persistence. Proc Natl Acad Sci U S A 2003; 100:241-6
16. Siddiqui KF, Amir M, Agrewala JN. Understanding the biology of 16 kDa antigen of Mycobacterium tuberculosis: Scope in diagnosis, vaccine design and therapy. Crit Rev Microbiol 2011; 37:349-57
17. Ramakrishnan L. Revisiting the role of the granuloma in tuberculosis. Nat Rev Immunol 2012; 12:352-66
18. Babu S, Bhat SQ, Kumar NP, Kumaraswami V, Nutman TB. Regulatory T cells modulate Th17 responses in patients with positive tuberculin skin test results. J Infect Dis 2009; 201:20-31
19. Herzmann C, Ernst M, Ehlers S, et al. Increased frequencies of pulmonary regulatory T-cells in latent Mycobacterium tuberculosis infection. Eur Respir J 2012; 40:1450-7
20. Schreiber HA, Hulseberg PD, Lee J, et al. Dendritic cells in chronic mycobacterial granulomas restrict local anti-bacterial T cell response in a murine model. PLoS One 2010; 5:e11453
21. Uehira K, Amakawa R, Ito T, et al. Dendritic cells are decreased in blood and accumulated in granuloma in tuberculosis. Clin Immunol 2002; 105:296-303
22. Khader SA, Bell GK, Pearl JE, et al. IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 2007; 8:369-77
23. Shklovskaya E, Fazekas de St Groth B. Balancing tolerance and immunity: The role of dendritic cell and T cell subsets. Methods Mol Biol 2007; 380:25-46
24. Das B, Kashino SS, Pulu I, et al. CD271(+) bone marrow mesenchymal stem cells may provide a niche for dormant Mycobacterium tuberculosis. Sci Transl Med 2013; 5:170ra13
25. Humphreys IR, Stewart GR, Turner DJ, et al. A role for dendritic cells in the dissemination of mycobacterial infection. Microbes Infect 2006; 8:1339-46
26. Schreiber HA, Harding JS, Hunt O, et al. Inflammatory dendritic cells migrate in and out of transplanted chronic mycobacterial granulomas in mice. J Clin Invest 2011; 121:3902-13
27. Sharma SK, Mohanan S, Sharma A. Relevance of latent TB infection in areas of high TB prevalence. Chest 2012; 142:761-73
28. Macatonia SE, Hosken NA, Litton M, et al. Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. J Immunol 1995; 154:5071-9
29. Popov A, Schultze JL. IDO-expressing regulatory dendritic cells in cancer and chronic infection. J Mol Med (Berl) 2008; 86:145-60
30. Sumpter TL, Thomson AW. The STATus of PD-L1 (B7-H1) on tolerogenic APCs. Eur J Immunol 2011; 41:286-90
31. Alderton GK. Tumour immunology: TIM3 suppresses antitumour DCs. Nat Rev Immunol 2012; 12:620-1
32. Chiba S, Baghdadi M, Akiba H, et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat Immunol 2012; 13:832-42
33. Bartz H, Avalos NM, Baetz A, Heeg K, Dalpke AH. Involvement of suppressors of cytokine signaling in toll-like receptor-mediated block of dendritic cell differentiation. Blood 2006; 108:4102-8
34. Baetz A, Frey M, Heeg K, Dalpke AH. Suppressor of cytokine signaling (SOCS) proteins indirectly regulate Toll-like receptor signaling in innate immune cells. J Biol Chem 2004; 279:54708-15
35. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 2007; 7:454-65
36. Barton BE. STAT3: A potential therapeutic target in dendritic cells for the induction of transplant tolerance. Expert Opin Ther Targets 2006; 10:459-70
37. Ouaaz F, Arron J, Zheng Y, Choi Y, Beg AA. Dendritic cell development and survival require distinct NF-kappaB subunits. Immunity 2002; 16:257-70
38. Zumla A, Raviglione M, Hafner R, von Reyn CF. Tuberculosis. N Engl J Med 2013; 368:745-55
39. Abebe M, Kim L, Rook G, et al. Modulation of cell death by M. tuberculosis as a strategy for pathogen survival. Clin Dev Immunol 2011; 2011:678570
40. Betts JC, Lukey PT, Robb LC, McAdam RA, Duncan K. Evaluation of a nutrient starvation model of Mycobacterium tuberculosis persistence by gene and protein expression profiling. Mol Microbiol 2002; 43:717-31
41. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009; 27:393-422
42. Trajkovic V, Natarajan K, Sharma P. Immunomodulatory action of mycobacterial secretory proteins. Microbes Infect 2004; 6:513-9
43. Khan N, Gowthaman U, Pahari S, Agrewala JN. Manipulation of costimulatory molecules by intracellular pathogens: Veni, vidi, vici!! PLoS Pathog 2012; 8:e1002676
44. Balboa L, Romero MM, Yokobori N, et al. Mycobacterium tuberculosis impairs dendritic cell response by altering CD1b, DC-SIGN and MR profile. Immunol Cell Biol 2010; 88:716-26
45. Ottenhoff TH. New pathways of protective and pathological host defense to mycobacteria. Trends Microbiol 2012; 20:419-28
46. Wang X, Zhang Z, Zhang S, et al. B7-H1 up-regulation impairs myeloid DC and correlates with disease progression in chronic HIV-1 infection. Eur J Immunol 2008; 38:3226-36
47. Imai K, Kurita-Ochiai T, Ochiai K. Mycobacterium bovis bacillus Calmette-Guerin infection promotes SOCS induction and inhibits IFNgamma-stimulated JAK/STAT signaling in J774 macrophages. FEMS Immunol Med Microbiol 2003; 39:173-80
48. Hu J, Winqvist O, Flores-Morales A, Wikstrom AC, Norstedt G. SOCS2 influences LPS induced human monocyte-derived dendritic cell maturation. PLoS One 2009; 4:e7178
49. Valencia J, Hernandez-Lopez C, Martinez VG, et al. Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features. J Immunol 2011; 187:4129-39
50. Li Y, Chu N, Rostami A, Zhang GX. Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 2006; 177:1679-88.